SERNOVA BIOTHERAPEUTICS INC (PSH0.DE) Stock Price, Forecast & Analysis
FRA:PSH0 • CA81752F1062
PSH0.DE Key Statistics, Chart & Performance
The current stock price of PSH0.DE is 0.0915 EUR. In the past month the price decreased by -12.86%.
PSH0.DE Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to PSH0.DE.
PSH0.DE Financial Highlights
Over the last trailing twelve months PSH0.DE reported a non-GAAP Earnings per Share(EPS) of -0.06. The EPS increased by 30.77% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -2060.13% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
PSH0.DE Forecast & Estimates
7 analysts have analysed PSH0.DE and the average price target is 2.31 EUR. This implies a price increase of 2428.15% is expected in the next year compared to the current price of 0.0915.
PSH0.DE Ownership
PSH0.DE Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ARGX | ARGENX SE | 28.53 | 44.21B | ||
| 1AE | ARGENX SE | 28.19 | 44.16B | ||
| 22UA | BIONTECH SE-ADR | N/A | 22.038B | ||
| ABVX | ABIVAX SA | N/A | 8.73B | ||
| 2X1 | ABIVAX SA | N/A | 8.73B | ||
| GLPG | GALAPAGOS NV | N/A | 1.911B | ||
| GXE | GALAPAGOS NV | N/A | 1.911B | ||
| IVA | INVENTIVA SA | N/A | 1.108B | ||
| NANO | NANOBIOTIX | N/A | 1.106B | ||
| 6IV | INVENTIVA SA | N/A | 1.075B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About PSH0.DE
Company Profile
Sernova Biotherapeutics Inc. is a clinical-stage biotechnology company, which engages in advancing regenerative medicine in the treatment of chronic diseases. The company is headquartered in London, Ontario and currently employs 17 full-time employees. A bio-hybrid organ is comprised of non-biomaterials, such as the Cell Pouch, integrated with living tissues to restore or enhance the function of a compromised organ. This approach aims to deliver a potentially revolutionary treatment for patients with chronic diseases, initially focusing on type 1 diabetes (T1D) and thyroid disorders. Cell Pouch is a bio-hybrid organ which is surgically implanted beneath the skin of the abdomen.
Company Info
SERNOVA BIOTHERAPEUTICS INC
700 Collip Circle, Ste 114
London ONTARIO CA
Employees: 8
Phone: 15198585184
SERNOVA BIOTHERAPEUTICS INC / PSH0.DE FAQ
Can you describe the business of SERNOVA BIOTHERAPEUTICS INC?
Sernova Biotherapeutics Inc. is a clinical-stage biotechnology company, which engages in advancing regenerative medicine in the treatment of chronic diseases. The company is headquartered in London, Ontario and currently employs 17 full-time employees. A bio-hybrid organ is comprised of non-biomaterials, such as the Cell Pouch, integrated with living tissues to restore or enhance the function of a compromised organ. This approach aims to deliver a potentially revolutionary treatment for patients with chronic diseases, initially focusing on type 1 diabetes (T1D) and thyroid disorders. Cell Pouch is a bio-hybrid organ which is surgically implanted beneath the skin of the abdomen.
What is the stock price of SERNOVA BIOTHERAPEUTICS INC today?
The current stock price of PSH0.DE is 0.0915 EUR. The price increased by 0.55% in the last trading session.
What is the dividend status of SERNOVA BIOTHERAPEUTICS INC?
PSH0.DE does not pay a dividend.
What is the ChartMill rating of SERNOVA BIOTHERAPEUTICS INC stock?
PSH0.DE has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
What is the market capitalization of PSH0 stock?
SERNOVA BIOTHERAPEUTICS INC (PSH0.DE) has a market capitalization of 30.81M EUR. This makes PSH0.DE a Nano Cap stock.